[ad_1]
Chinook Therapeutics
(KDNY) stock surged 66% in premarket trading Monday after Swiss pharmaceutical company
Novartis
(NVS) agreed to buy the biopharma company for up to $3.5 billion.
[ad_2]
Source link
